SCHEMBL5108398

SCHEMBL5108398

CNC(=O)n1ccc2cc(Nc3cc(NC(=O)N4CCOCC4)ncn3)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 6/20 0.42
NPC1 O15118 3/20 0.42
HSD17B10 Q99714 1/20 0.42
GSK3B P49841 4/20 0.42
DYRK1A Q13627 4/20 0.42
NPY5R Q15761 3/20 0.41
JAK3 P52333 2/20 0.41
GAA P10253 3/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
RAB9A P51151 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TP53 P04637 1/20 0.39
ESR2 Q92731 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13999505 0.88 SMN1; SMN2 (0.41) KDM4EALDH1A1SMN1; SMN2NPC1HSD17B10
SCHEMBL5115503 0.84 FGFR1 (0.46) SMN1; SMN2GSK3BDYRK1AMAPTESR2
SCHEMBL5104598 0.80 KDR (0.43)
SCHEMBL1248303 0.79 FGFR1 (0.48)
SCHEMBL5104367 0.77 FGFR1 (0.46) GSK3BDYRK1AMAPTESR2
SCHEMBL5115135 0.76 CYP3A4 (0.42) SMN1; SMN2GSK3BDYRK1AMAPTESR2
SCHEMBL5108785 0.75 CYP3A4 (0.41) KDM4ESMN1; SMN2NPC1GSK3BDYRK1A
SCHEMBL28768530 0.75 KDM4E (0.37) KDM4EALDH1A1SMN1; SMN2NPC1HSD17B10
SCHEMBL13999504 0.74 CYP3A4 (0.44) SMN1; SMN2GSK3BDYRK1AMAPTMEN1
SCHEMBL5102769 0.74 CYP3A4 (0.42) SMN1; SMN2GSK3BDYRK1AMAPTESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7468380-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-12-23 US disclosed
US-7468380-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-12-23 US disclosed
US-7468380-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-12-23 US disclosed
CN-100339376-C Nitrogen-containing aromatic ring derivatives EISAI CO LTD (JP) 2007-09-26 CN disclosed
US-20070004764-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-01-04 US disclosed
US-20070004764-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-01-04 US disclosed
US-20070004764-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-01-04 US disclosed
US-7109219-B2 Nitrogen-containing aromatic derivatives EISAI CO., LTD. (JP) 2006-09-19 US disclosed
US-20060004029-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-01-05 US disclosed
US-20050187236-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-08-25 US disclosed
EP-1522540-A1 AZAARENE DERIVATIVES Eisai Co., Ltd. (JP) 2005-04-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004029-A1 Nitrogen-containing aromatic derivatives NR0B2, NR0B1, NR4A1 KDM4E 2341/4885ALDH1A1 1501/4885SMN1; SMN2 3950/4885
US-20050187236-A1 Nitrogen-containing aromatic derivatives NR0B2, NR0B1, NR4A1 KDM4E 2341/4885ALDH1A1 1501/4885SMN1; SMN2 3950/4885
US-20070004764-A1 Nitrogen-containing aromatic derivatives NR0B2, NR0B1, NR4A1 KDM4E 2341/4885ALDH1A1 1501/4885SMN1; SMN2 3950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.